cotinine and 2019 Novel Coronavirus Disease

cotinine has been researched along with 2019 Novel Coronavirus Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's6 (100.00)2.80

Authors

AuthorsStudies
Aoike, M; Aoyama, Y; Hotta, K; Ito, M; Kawamura, H; Kozai, H; Mori, Y; Shigeno, Y; Tanaka, M; Tsurudome, M1
Belsey, J; Caci, G; Cantone, GG; Caraci, F; Cibella, F; Ferrante, M; Ferrara, P; Ferri, R; Polosa, R; Romano, C; Romeo, AC; Rose, J; Rust, S; Saitta, D; Thangaraju, M; Tomaselli, V; Zuccarello, P1
Dove, MS; Khan, N; Leistikow, BN; Tong, EK1
Bauld, L; Boyd, KA; Dick, A; Harris, FM; Hewitt, C; Hoddinott, P; Keding, A; Kee, F; McFadden, M; McKell, J; McMeekin, N; Mitchell, A; Robinson-Smith, L; Sinclair, L; Tappin, D; Torgerson, D; Ussher, M; Watson, J; Watson, S1
Dumke, R; El-Armouche, A; Helm, B; Mayer, R; Oertel, R; Renner, B; Schubert, S1
Mehan, S; Sharma, T1

Reviews

1 review(s) available for cotinine and 2019 Novel Coronavirus Disease

ArticleYear
Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker.
    Infectious disorders drug targets, 2021, Volume: 21, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Cotinine; COVID-19; Humans; Peptidyl-Dipeptidase A; Respiratory Distress Syndrome; SARS-CoV-2

2021

Trials

1 trial(s) available for cotinine and 2019 Novel Coronavirus Disease

ArticleYear
Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial.
    BMJ (Clinical research ed.), 2022, 10-19, Volume: 379

    Topics: Adolescent; Anabasine; Cotinine; COVID-19; Female; Humans; Motivation; Pregnancy; Pregnant Women; Scotland; Smoking; Smoking Cessation; Tobacco Use Cessation Devices

2022

Other Studies

4 other study(ies) available for cotinine and 2019 Novel Coronavirus Disease

ArticleYear
Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence.
    Drug discoveries & therapeutics, 2022, May-17, Volume: 16, Issue:2

    Topics: Antibodies, Viral; Antibody Formation; BNT162 Vaccine; Cotinine; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; mRNA Vaccines; SARS-CoV-2; Smokers; Tobacco Products; Vaccination; Vaccines, Synthetic

2022
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey.
    Internal and emergency medicine, 2022, Volume: 17, Issue:6

    Topics: Antibodies, Viral; Cotinine; COVID-19; COVID-19 Testing; Humans; Immunoglobulin G; Pandemics; SARS-CoV-2; Smoking

2022
Current Smoking and Risk of Coronavirus Infection and Illness in a Highly Controlled Challenge Study: A Re-analysis of the British Cold Study.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 05-22, Volume: 25, Issue:6

    Topics: Adult; Cotinine; COVID-19; Humans; Smoking; Smoking Cessation; Tobacco Smoking

2023
Drug consumption in German cities and municipalities during the COVID-19 lockdown: a wastewater analysis.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:5

    Topics: Amphetamine; Cities; Communicable Disease Control; Cotinine; COVID-19; Humans; Illicit Drugs; Metoprolol; Nicotine; SARS-CoV-2; Substance-Related Disorders; Wastewater; Water Pollutants, Chemical

2023